(Adds Outlook)
Looking ahead, GoodRx Holdings, Inc. (GDRX) expects a rise in first quarter and full-year revenue.
For the first quarter of 2025, GoodRx expects revenue of $201 to $205 million, in line with analysts' forecast of $202.58 million. For the same quater of the prior year, the company had recorded revenue of $197.9 million.
For the full-year 2025, GDRX anticipates adjusted EBITDA of $270 to $286 million, up from the $260.2 million of 2024.
GoodRx projects its annual revenue to be in the range of $810 to $840 million, in line with Street view of $825.6 million. For the full-year 2024, the company had recorded revenue of $792.3 million.
Q4 Results:
Below are the earnings highlights for GoodRx Holdings, Inc. (GDRX):
Earnings: $6.740 million in Q4 vs. -$25.869 million in the same period last year. EPS: $0.02 in Q4 vs. -$0.06 in the same period last year. Excluding items, GoodRx Holdings, Inc. reported adjusted earnings of $34.748 million or $0.09 per share for the period.
Analysts projected $0.1 per share Revenue: $198.583 million in Q4 vs. $196.644 million in the same period last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.